DNA vaccination is an attractive vaccination method. First, the production of plasmid DNA as a vaccine is considerably more cheap and simple than the production of recombinant protein. Second, the expression cassette of DNA vaccines can readily be modified, making DNA vaccines highly flexible. Finally, in animal models, DNA vaccination is able to induce potent cellular immune responses.
Over the past decade, the focus in the DNA vaccination field has in large part moved from intramuscular immunization towards dermal administration. As a natural “porte d’entrée” for pathogens, the skin is rich in antigen-presenting cells, which are required for generating an efficient antigen-specific immune response.
This chapter describes a DNA vaccination protocol that utilizes a simple tattooing device for the dermal delivery of plasmid DNA. This technique, called DNA tattooing, is capable of generating high frequencies of antigen-reactive T cells in mice and macaques.
DNA vaccination Tattooing Intradermal delivery Immune response Plasmid DNA
This is a preview of subscription content, log in to check access.
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
Nagata T, Aoshi T, Uchijima M et al (2004) Cytotoxic T-lymphocyte-, and helper T-lymphocyte-oriented DNA vaccination. DNA Cell Biol 23:93–106PubMedCrossRefGoogle Scholar
van Rooij N, van Buuren MM, Philips D et al (2013) Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. J Clin Oncol 31:e439PubMedCrossRefGoogle Scholar
Lu YC, Yao X, Li YF et al (2013) Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression. J Immunol 190:6034–6042PubMedCrossRefGoogle Scholar
Kanitakis J (2002) Anatomy, histology and immunohistochemistry of normal human skin. Eur J Dermatol 12:390–399PubMedGoogle Scholar
Kataru RP, Jung K, Jang C et al (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113:5650–5659PubMedCrossRefGoogle Scholar
Shklovskaya E, Roediger B, Fazekas de St GB (2008) Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo. J Immunol 181:418–430PubMedCrossRefGoogle Scholar
Stoecklinger A, Grieshuber I, Scheiblhofer S et al (2007) Epidermal langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunization. J Immunol 179:886–893PubMedCrossRefGoogle Scholar
Wolkers MC, Toebes M, Okabe M et al (2002) Optimizing the efficacy of epitope-directed DNA vaccination. J Immunol 168:4998–5004PubMedCrossRefGoogle Scholar
Oosterhuis K, Aleyd E, Vrijland K et al (2012) Rational design of DNA vaccines for the induction of human papillomavirus type 16 E6- and E7-specific cytotoxic T-cell responses. Hum Gene Ther 23:1301–1312PubMedCrossRefGoogle Scholar
van den Berg JH, Quaak SG, Beijnen JH et al (2010) Lipopolysaccharide contamination in intradermal DNA vaccination: toxic impurity or adjuvant? Int J Pharm 390:32–36PubMedCrossRefGoogle Scholar
Toebes M, Rodenko B, Ovaa H et al (2009) Generation of peptide MHC class I monomers and multimers through ligand exchange. Curr Protoc Immunol 87:18.16.1–18.16.20Google Scholar
Oosterhuis K, Ohlschlager P, van den Berg JH et al (2011) Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7. Int J Cancer 129:397–406PubMedCrossRefGoogle Scholar